{{Rsnum
|rsid=2076546
|Gene=NCOA3
|Chromosome=20
|position=47639749
|Orientation=minus
|GMAF=0.1226
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NCOA3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 15.9 | 81.4
| HCB | 0.7 | 13.1 | 86.1
| JPT | 2.7 | 25.7 | 71.7
| YRI | 4.8 | 35.4 | 59.9
| ASW | 1.8 | 47.4 | 50.9
| CHB | 0.7 | 13.1 | 86.1
| CHD | 1.8 | 19.3 | 78.9
| GIH | 0.0 | 8.9 | 91.1
| LWK | 9.1 | 42.7 | 48.2
| MEX | 0.0 | 8.6 | 91.4
| MKK | 7.1 | 43.6 | 49.4
| TSI | 2.9 | 20.6 | 76.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=20003447
|Title=Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}